The absence of SR-A staining determined by immunohistochemistry indicates that TAMs in nodal CHL are phenotypically different than resident tissue macrophages, and TAMs in other malignancies including extranodal CHL, THRLBCL, and lymph nodes with metastatic carcinoma. This evidence concerns the gene MSR1 and metastatic carcinoma.